Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NSE - Delayed Quote INR

Advanced Enzyme Technologies Limited (ADVENZYMES.NS)

Compare
294.95
+9.80
+(3.44%)
At close: 3:29:48 PM GMT+5:30
Loading Chart for ADVENZYMES.NS
  • Previous Close 285.15
  • Open 281.25
  • Bid --
  • Ask --
  • Day's Range 281.25 - 296.00
  • 52 Week Range 257.90 - 571.00
  • Volume 127,715
  • Avg. Volume 252,977
  • Market Cap (intraday) 32.999B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 24.87
  • EPS (TTM) 11.86
  • Earnings Date May 9, 2025 - May 13, 2025
  • Forward Dividend & Yield 5.10 (1.79%)
  • Ex-Dividend Date Jul 18, 2024
  • 1y Target Est --

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.

www.advancedenzymes.com

323

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ADVENZYMES.NS

View More

Performance Overview: ADVENZYMES.NS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ADVENZYMES.NS
15.33%
S&P BSE SENSEX (^BSESN)
2.36%

1-Year Return

ADVENZYMES.NS
18.07%
S&P BSE SENSEX (^BSESN)
3.27%

3-Year Return

ADVENZYMES.NS
5.86%
S&P BSE SENSEX (^BSESN)
28.71%

5-Year Return

ADVENZYMES.NS
133.95%
S&P BSE SENSEX (^BSESN)
176.52%

Compare To: ADVENZYMES.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ADVENZYMES.NS

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    31.90B

  • Enterprise Value

    27.15B

  • Trailing P/E

    24.02

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.09

  • Price/Book (mrq)

    2.38

  • Enterprise Value/Revenue

    4.33

  • Enterprise Value/EBITDA

    12.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.18%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.28B

  • Net Income Avi to Common (ttm)

    1.33B

  • Diluted EPS (ttm)

    11.86

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.07B

  • Total Debt/Equity (mrq)

    3.38%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ADVENZYMES.NS

View More

Company Insights: ADVENZYMES.NS

Research Reports: ADVENZYMES.NS

View More

People Also Watch